‘I shot Mr Thompson’- What it was like inside court as Mangione pleaded guilty

Mangione Enters Guilty Plea in UnitedHealthcare CEO Shooting Case

Ninoda.com – Luigi Mangione stood before a federal courtroom in New York on Friday, marking a pivotal moment after more than eighteen months of legal proceedings and public attention. The 28-year-old defendant, who faces charges for the fatal shooting of UnitedHealthcare chief executive Brian Thompson, formally entered a guilty plea. The incident occurred on a Manhattan street during December 2024.

Arriving in a beige prison uniform layered over a white T-shirt, Mangione presented with shackled feet and hands positioned behind his back. US marshals chose not to handcuff him during his appearance. The courtroom filled with journalists, supporters, observers, and select court staff members who had secured attendance through a lottery system.

The Courtroom Proceedings

Thompson’s family occupied the front row behind the prosecution, displaying visible emotion throughout the hearing. As attendees awaited Judge Margaret Garnett’s arrival, Mangione worked alongside his attorney Karen Friedman Agnifilo, examining documents while preparing for what might be his first public admission of guilt.

The hearing commenced shortly after the scheduled 11:00 AM start time. Friedman Agnifilo immediately announced to the bench: “Mr Mangione is prepared to plead guilty at this time.” Following this declaration, the courtroom fell quiet as Judge Garnett posed a series of questions to verify Mangione’s understanding of his decision.

“I shot Mr Thompson in Manhattan and he died.”

The judge inquired about his medical history and medication usage. Mangione responded with brief but confident answers. When asked whether he comprehended the possibility of receiving a life sentence, he simply replied “yes.” His composure remained steady until Judge Garnett began reading his prepared statement to the court.

Initially, Mangione’s delivery appeared hurried and somewhat unclear. After the judge gently encouraged him to speak closer to the microphone, his speech stabilized as he reached his conclusion—an acknowledgment of responsibility for Thompson’s death.

Motivations and Methods

Contrary to widespread media speculation about a potential plea agreement, Mangione merely transitioned from a not guilty to a guilty plea without any negotiated deal. His statement revealed personal motivations rooted in both health struggles and frustration with the insurance sector.

“After years of enduring severe pains from a broken back” and dealing with the healthcare insurance industry, Mangione stated that he had learned UnitedHealthcare would hold an annual conference in Manhattan in December 2024.

According to his court statement, Mangione conducted online research and contacted the company under the guise of an investor to gather information about the upcoming event. He noted that he received a prompt response, remarking: “Unlike previous interactions with insurance” he got a quick reply.

Mangione explained that he utilized a 3D printer to construct the weapon used in the shooting. On the morning of December 4, 2024, he carried out the fatal encounter on Manhattan streets.

Legal Aftermath and Sentencing

When Judge Garnett asked Mangione how he now pleaded, he leaned toward the microphone and declared: “Guilty.” The judge accepted his plea, stating: “I will accept your guilty plea.” Thompson’s family members showed visible emotion as the admission was formally recorded.

In a subsequent statement, the Thompson family described the day as representing a significant advancement toward justice. Mangione faces sentencing on December 18, with prosecutors recommending a prison term between 24 and 30 years. Each of the two stalking charges carries a maximum penalty of life imprisonment, though Judge Garnett retains final authority over the sentence.

Separate state proceedings related to the murder remain on track to commence in September. Mangione’s guilty plea addresses federal charges, while his state trial will proceed independently.